NCT06190704View on ClinicalTrials.gov

Prognostic Significance of CMD Assessed by IMR in HCM Patients

CompletedOBSERVATIONAL
Enrollment

191

Participants

Timeline

Start Date

September 13, 2014

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Coronary Cicrovascular DysfunctionHypertrophic Cardiomyopathy Patients
Interventions
DEVICE

caIMR

Coronary angiography-derived IMR (caIMR) is a novel and accurate alternative that can enable the assessment of coronary microvascular function easier, and more efficiently and does not require pressure wire or adenosine.

All Listed Sponsors
lead

Ya-Wei Xu

OTHER

NCT06190704 - Prognostic Significance of CMD Assessed by IMR in HCM Patients | Biotech Hunter | Biotech Hunter